Close
Help
Need Help?



Translational Oncogenomics Now Uses Project Counter Analytics

Posted Tue, May, 08,2012

Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Translational Oncogenomics.

One of the ways we measure an article's visibility is the number of views and downloads it receives.  The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal's visibility figure.

Counting views and downloads is complicated by the possibility of fraud and automated views by search engines.  To ensure that readers and authors can have confidence in our visibility analytics we have now formally joined Project Counter.  Release 3 of Project Counter's code of practice addresses these and other problems.

Translational Oncogenomics' membership of Project Counter ensures that readers and authors can trust its visibility analytics.

Visit this page to see the latest visibility information for Translational Oncogenomics.

share on

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
I would like to congratulate Clinical Medicine Insights: Endocrinology and Diabetes for the professional way it manages the entire publication process.  I am certain it will have a bright future, and reach top positions among endocrine and metabolic journals.
Dr Francisco Bandeira (University of Pernambuco Medical School, Recife, Brazil)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results